Bio-AI developed an automated pathology machine learning algorithm for detecting Non small cell lung cancer
Predict TMB Status From H&E-Stained Tissue Slides for NSCLC Adenocarcinoma
We integrate complex multi-omic data from clinical trials
We integrate complex multi-omic data from clinical trials and translational studies using our Bio AI Platform. We use AI to determine which predictors can improve patient selection criteria & increase success rates for clinical programs.
We have the capability to develop machine learning models on multi-omic data that can help predict patient response to therapy & drug resistance.